Colorectal Neoplasms: all 5,734 studies
Page 7 of 58. Open to participants first (1,481), then studies with results posted, then the rest; newest registration first within each.
- Lipid Mediators & Cancer: Montelukast, SPM, and AlmondsNot yet recruitingNCT06887673Early Phase 1
- 5-Fluorouracil/Leucovorin (5FU/LV) in Combination With Regorafenib in Patients With Metastatic Colorectal CancerRecruitingNCT06887218Phase 2
- A Long-Term Follow-Up Study of Participants Treated With A2 Biotherapeutics (A2 Bio) Gene Therapy (GT) ProductsEnrolling by invitationNCT06885424
- A Study to Test the Safety and Effectiveness of GSK5764227, Alone or With Other Treatments, in Participants With Advanced Gastrointestinal Cancers That Cannot be Surgically Removed (EMBOLD PanGI-201)RecruitingNCT06885034Phase 1/2
- Efficacy and Safety of Trifluridine/Tipiracil (TAS-102) Combined With Bevacizumab and Serplulimab in Patients With Metastatic Colorectal Cancer Undergoing Cytoreductive Surgery: A Single-Arm, Single-Center Clinical StudyNot yet recruitingNCT06882915Phase 1
- Intrathecal Morphine Versus Epidural Analgesia for Laparoscopic Colon SurgeryNot yet recruitingNCT06881563Phase 4
- CapeOX Combined With Bevacizumab Plus Anti-PD1 Antibody as Neoadjuvant Therapy for Locally Recurrent Colorectal CancerRecruitingNCT06881537Phase 2
- MRD-Guided Surveillance in Resectable Stage IV Metastatic Colorectal Cancer (SURVEILLANCE-II)Not yet recruitingNCT06879886
- Precision-MRD: Prospective Observational Study of Biomarker-directed Systemic Therapy for Colorectal Cancer Patients With Minimal Residual DiseaseRecruitingNCT06878131
- Nelmastobart in Combination With Trifluridine/ Tipiracil and Bevacizumab in Metastatic/ Recurrent Colorectal CancerRecruitingNCT06873763Phase 1/2
- Chlorhexidine Gluconate Versus Saline for Flushing the Surgical Area During Colorectal Cancer SurgeryRecruitingNCT06869096Not applicable
- Multi-Center Study Protocol: Impact of Sarcopenia in Early-Onset Colorectal Cancer.Enrolling by invitationNCT06868095
- Efficacy and Safety of Colorectal Anastomotic Leak TestingRecruitingNCT06865638Not applicable
- Predictive Value of PREMM5, MMRpredict, and Universal Tumor Screening for Lynch Syndrome in VietnamNot yet recruitingNCT06863038
- Trial of Gum Chewing to Enhance the Restoration of Intestinal Motility in Colorectal Cancer SurgeryNot yet recruitingNCT06860685Phase 1/2
- Chidamide in Combination With PD-1 Inhibitor, Bevacizumab, and XELOX for Metastatic Colorectal CancerNot yet recruitingNCT06858969Phase 2
- Real-World Study of Chidamide Combined With PD-(L)1 Inhibitors and Anti-Angiogenic Therapy for Advanced MSS-Type Colorectal CancerNot yet recruitingNCT06858956
- Induction Treatment for Initially Unresectable Colorectal Liver Metastases: Combined Hepatic Arterial Infusion Pump Therapy With Systemic TherapyRecruitingNCT06857773Phase 3
- - IKF/AIO-QUINTIS - Evaluating Fruquintinib in Combination With Tislelizumab in Microsatellite Stable / Proficient Mismatch Repair (MSS/pMMR) Metastatic Colorectal Cancer Without Active Liver MetastasesRecruitingNCT06856837Phase 2
- The Role of Coenzyme Q10 in the Prophylaxis of Oxaliplatin Induced Peripheral Neuropathy in Patients With Colorectal CancerRecruitingNCT06856447Phase 1
- Second-line Standard Treatment Sequential TAS-102 and Bevacizumab Combined With Local Treatment in Advanced Colorectal CancerRecruitingNCT06856187Phase 2
- An Open-label, Single-arm, Multicenter Phase II Study to Evaluate the Efficacy of Amivantamab in Combination With FOLFIRI as a Second-line Treatment in Patients With RAS/BRAF Wild-type Advanced Colorectal Cancer Progressing on Prior Anti-EGFR Based Treatment.Not yet recruitingNCT06855849Phase 2
- Study of a Tankyrase Inhibitor RK-582 for Patients With Unresectable Metastatic Colorectal CancerRecruitingNCT06853496Phase 1
- SCRT-CAPEOX-Serplulimab for MSS/pMMR Rectal Cancer With OligometastasesRecruitingNCT06850103Phase 2
- Multicenter Retrospective Study on Optimizing Combination Immunotherapy Strategies in MSS/MSI-L/pMMR Advanced Colorectal CancerEnrolling by invitationNCT06849362
- LDRT Combined With Immunochemotherapy for Colorectal Cancer With Liver MetastasisRecruitingNCT06848465Phase 1
- Neoadjuvant ADG126 and Pembrolizumab in Locally Advanced Colorectal CancerRecruitingNCT06846268Phase 2
- A Clinical Study to Evaluate the Safety and Tolerability of AWT020 in Patients With Advanced MalignanciesRecruitingNCT06839105Phase 1
- Prophylactic PIPAC in Patients With High-risk Colorectal CancerNot yet recruitingNCT06839092Phase 3
- A Multicenter, Open Phase IIb Clinical Study to Evaluate the Efficacy and Safety of B1962 Injection in the Treatment of Advanced Colorectal CancerNot yet recruitingNCT06838546Phase 2
- A Study to Learn About Study Medicine ALTA3263 in Adults With Advanced Solid Tumors With KRAS MutationsRecruitingNCT06835569Phase 1
- SBRT Combined With CAPEOX, Bevacizumab, and PD-1 Inhibitor for the Treatment of RAS-Mutant, MSS-Type, Unresectable Metastatic Colorectal Cancer.Not yet recruitingNCT06835179Phase 2
- Phase I Trial of 5-Fluorouracil (5FU) -Based Therapy in Combination With Hydroxytyrosol (HT) in Patients With Advanced or Metastatic Colorectal CancerRecruitingNCT06833866Phase 1
- Screening for Hepatitis Virus B Protein X (HBx) in Colitis-associated Cancer (CAC)Not yet recruitingNCT06833021
- Nanocrystalline Megestrol for First-line Treatment of Advanced Gastric or Colorectal Cancer With Cancer-related FatigueRecruitingNCT06830018Not applicable
- "Thymalfasin Immunotherapy Study with Triple Regimen in Advanced MSS/pMMR Colorectal Cancer"RecruitingNCT06829355Phase 2
- Lifestyle Intervention Among Participants of the French Colorectal Cancer Screening Program (LIFE-SCREEN)RecruitingNCT06827366Not applicable
- ARTEMIS-102: HS-20093 Combinations in Patients with Advanced Metastatic Colorectal CancerRecruitingNCT06825624Phase 1
- Evaluation of RBS2418 in Patients With Advanced, Metastatic, and Progressive Colorectal CancerRecruitingNCT06824064Phase 2
- The Study on the Efficacy and Safety of Lactobacillus Johnsonii in Combination with CapeOX and Pembrolizumab for the Treatment of MSS/pMMR Metastatic Colorectal Cancer.Not yet recruitingNCT06823323Not applicable
- Advances in Imaging to Assess Response in Rectal CancerRecruitingNCT06822634
- A Multilevel Intervention to Increase Colorectal Cancer Screening Tests in Patients With Abnormal Fecal Immunochemical Test Results, PROACT TrialRecruitingNCT06822530Not applicable
- Raman Spectroscopy-Based Deep Learning Model for Early Pan-Cancer Early DiagnosisRecruitingNCT06822413
- Study of CEA Targeting CAR-T (PTC13) in the Treatment of CEA-Positive Advanced Malignant Solid TumorsRecruitingNCT06821048Phase 1
- A Study to Evaluate the Adverse Events, and Efficacy of Intravenous (IV) of Telisotuzumab Adizutecan in Combination With IV Oxaliplatin, Fluorouracil, Folinic Acid/Leucovorin, Bevacizumab, Panitumumab in Adult Participants With Metastatic Colorectal CancerRecruitingNCT06820463Phase 2
- Phase I/II Clinical Study to Evaluate VB15010 Tablets in Patients With Advanced Solid TumorsRecruitingNCT06819215Phase 1/2
- Recurrence Rate After Endoscopic Resection of , Laterally Spreading Tumor Granular Type (LST-G) of the Colon and Rectum: Endoscopic Mucosal Resection vs. Endoscopic Submucosal DissectionRecruitingNCT06815406Not applicable
- Mindfulness-based Intervention for Depressive Symptoms Sent Via Text (MINDSET)Not yet recruitingNCT06811454Not applicable
- Effects of Endocrine Disruptors on the Gut Microbiota and Assessment of Their Impact on Colorectal Cancer Development (PERMICA)RecruitingNCT06809660Not applicable
- Real World Multicenter National Study to Evaluate the Effectiveness and Safety of Biosimilar Bevacizumab ElovieRecruitingNCT06808685
- Complete Closure After Endoscopic Mucosal Resection of Large Non-Pedunculated Colorectal PolypsRecruitingNCT06807073Not applicable
- Artificial Intelligence-based Screening Models for Prevention and Early Detection of Colorectal CancerRecruitingNCT06799793Not applicable
- Study on the Impact of a Modified Mediterranean Diet, in Patients With Colorectal Cancer Undergoing Active Medical Oncology TreatmentRecruitingNCT06794931Not applicable
- SBRT + PD-1 Monoclonal Antibody in Unresectable Colorectal Liver MetastasesRecruitingNCT06794086Phase 3
- Surveillance Intervals After Piecemeal Resection of Non-pedunculated Colorectal Lesions ≥20mmNot yet recruitingNCT06791616Not applicable
- mFOLFOX6 + Bevacizumab + PD-1 Monoclonal Antibody Vs. mFOLFOX6 in Locally Advanced pMMR/MSS CRCRecruitingNCT06791512Phase 3
- A Phase 1, First-in-human Study of OKN4395 and Pembrolizumab in Patients With Solid TumorsRecruitingNCT06789172Phase 1
- Development of Organoids From Primary Colorectal Tumors and Synchronous Liver MetastasesRecruitingNCT06787625
- Fruquintinib in Patients With Metastatic Colorectal CancerRecruitingNCT06787105
- A First-in-Human Escalation and Expansion Study of Patients With Advanced Solid TumorsRecruitingNCT06783569Phase 1
- Efficacy of the Use of Neoadjuvant With/Without Hyperthermic Intraperitoneal Chemotherapy in the Treatment of Locally Advanced Colon CancerRecruitingNCT06783491Phase 3
- Low Versus Standard Intraabdominal Pressure in Robot-assisted Colorectal Cancer SurgeryRecruitingNCT06783244Not applicable
- Structural Characteristics of Trunk and Limb Muscles in Cachectic Colorectal Cancer PatientsRecruitingNCT06780423
- Sintilimab in Combination with Cetuximab and Chemotherapy As First-line Treatment for RAS/BRAF Wild-type Advanced Colorectal CancerRecruitingNCT06776757Phase 1/2
- Fecal Immunochemical Test in Diagnosing Colorectal Cancer Among Vietnamese Patients with Lower Gastrointestinal SymptomsNot yet recruitingNCT06776120Not applicable
- Appropriateness of Colonoscopy Indication: an Evaluation of the Clinical and Economic Impact.RecruitingNCT06775951
- DYNAMICS-LYNCH：DNA Methylation Analysis in Stool for Screening of Lynch Syndrome-Associated Colorectal CancerNot yet recruitingNCT06772844
- Ga-68-FAPI-46 PET for CRC Recurrence Detection in Elevated CEARecruitingNCT06769828Not applicable
- Comparing Immediate Removal and Postoperative 1 Day of Urinary Catheter After Colorectal Cancer SurgeryEnrolling by invitationNCT06769087Not applicable
- Effect of Genetic Polymorphism on Capecitabine-Induced Toxicity in Egyptian Cancer PatientsRecruitingNCT06765252
- A Study of BMS-986488 as Monotherapy and Combination Therapy in Participants With Advanced Malignant TumorsRecruitingNCT06764771Phase 1
- Irinotecan Liposomes Combined with Cetuximab + Vermofenib in First-line Failure of Advanced Colorectal CancerRecruitingNCT06763029Phase 2
- A Study to Learn More About How Well Treatment With Sevabertinib (BAY 2927088) Tablets Works and How Safe it is in Participants Who Have a Solid Tumor With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2)RecruitingNCT06760819Phase 2
- A Phase I/ II Study of Fragmented Autoantigen Stimulated T-cell-immunotherapy Combined with Radiotherapy (FAST-CR)Not yet recruitingNCT06756295Early Phase 1
- CT-95 in Advanced Cancers Associated With Mesothelin ExpressionRecruitingNCT06756035Phase 1
- Role of Photon Counting CT in Detecting Liver Metastatis From Colorectal CancerRecruitingNCT06753903
- Neoantigen-based Peptide Vaccine and Conventional Third-line Therapy for CRC Progressed After Second-line TreatmentRecruitingNCT06751966Not applicable
- Neoantigen-loaded DC Vaccine and Conventional Third-line Therapy for CRC Progressed After Second-line TreatmentRecruitingNCT06751953Not applicable
- Neoantigen-loaded DC Vaccine and Conventional Second-line Therapy for CRC Progressed After First-line TreatmentRecruitingNCT06751940Not applicable
- Neoantigen-based Peptide Vaccine and Conventional Second-line Therapy for CRC Progressed After First-line TreatmentRecruitingNCT06751914Not applicable
- Expanded Access Program (EAP) Designed to Provide Access to Botensilimab and Balstilimab Before Regulatory ApprovalAvailableNCT06751524
- A Study of DM002 in Patients With Advanced Solid TumorsRecruitingNCT06751329Phase 1/2
- A Study of Amivantamab and FOLFIRI Versus Cetuximab/Bevacizumab and FOLFIRI in Participants With KRAS/NRAS and BRAF Wild-type Colorectal Cancer Who Have Previously Received ChemotherapyRecruitingNCT06750094Phase 3
- A Study on Treatment for Patients With BRAFV600E Mutant Metastatic Colorectal Cancer (mCRC)RecruitingNCT06749015
- A Prospective, Open-label, Single-arm Phase II Clinical Study of Fruquintinib Combined With S-1 for the Treatment of Metastatic Colorectal Cancer.Not yet recruitingNCT06746545Phase 2
- Multilevel Action Toward Colorectal Cancer and Hepatitis C Education and ScreeningRecruitingNCT06745895Not applicable
- Improving Colorectal Cancer Early Screening in Portugal: Identification of Gut Microbiome Biomarkers in Stool (GUTBIOME-PT)RecruitingNCT06741293
- Serum MicroRNAs as Diagnostic Biomarkers of Colorectal CancerNot yet recruitingNCT06738225
- Microbiome-based Diagnostic Tool for the Screening of Colorectal Cancer (GUILTI)RecruitingNCT06738173
- CARE-CRC: Microbiome Insights and Correlations for Risk and Outcomes in Colorectal CancerRecruitingNCT06734156
- FOLFOXIRI Plus Bevacizumab With or Without Atezolizumab as 1st Line Treatment of pMMR and IS IC-High Metastatic Colorectal Cancer Patients.RecruitingNCT06733038Phase 3
- Optimal Perioperative Pain Control in Minimally Invasive Abdominal Cancer SurgeryRecruitingNCT06731998Not applicable
- Implementation of the ERAS in Colorectal Cancer Patients: a Single Arm StudyEnrolling by invitationNCT06729736Not applicable
- Addition of Antibiotics to Upfront Treatment Regimen for Colorectal CancerRecruitingNCT06728072Phase 2
- A Study of MGC028 in Participants With Advanced Solid TumorsRecruitingNCT06723236Phase 1
- Different Same-day Colonoscopic Bowel Preparation Procedures on Patient Compliance, Tolerability, and Bowel CleansingNot yet recruitingNCT06722209Not applicable
- Futibatinib in Combination With (Chemo)Immunotherapy in Colorectal Cancer and Other Solid Tumor EntitiesRecruitingNCT06722183Phase 2
- A Study to Investigate the Safety and Efficacy of KQB365 as Monotherapy and in Combination in Participants With Advanced Solid MalignanciesRecruitingNCT06720987Phase 1
- Reduce Sedentary Behavior During Cancer Treatment - the RedSedCan StudyRecruitingNCT06719206Not applicable
- Clinical Study of IM96 CAR-T Cell Therapy in Patients With Advanced Colorectal CancerRecruitingNCT06718738Phase 1